Target intelligence / Profile preview

Intestinal mineral absorption pathway

Molecular classification
Other
01

Overview

The intestinal mineral absorption pathway refers collectively to the physiological and molecular processes by which dietary minerals—including but not limited to calcium, iron, zinc, copper, and phosphate—are absorbed from the intestinal lumen into enterocytes and then transported into systemic circulation. This process is highly regulated due to both the essential nature and potential toxicity of many minerals at high concentrations[2][4]. Absorption occurs primarily in the small intestine via two main routes: transcellular (active) transport involving specific membrane proteins such as channels or pumps—often regulated by hormones like vitamin D—and paracellular (passive) diffusion through tight junctions between epithelial cells[1][2][3][5]. For example, active transcellular calcium uptake is upregulated by vitamin D via increased expression of calbindin and other related proteins[3], while passive paracellular movement predominates when luminal concentrations are high. Iron is actively transported into enterocytes where it binds ferritin before being released according to systemic needs[1]. The efficiency and selectivity of these pathways are critical for maintaining overall mineral homeostasis. Note: "Intestinal mineral absorption pathways" does not refer to a single molecule or receptor but rather an ensemble of physiological processes involving multiple distinct molecular targets. Therefore this entry should be flagged as not a canonical therapeutic target but rather a functional category encompassing several targets such as divalent metal transporter 1 (DMT1), TRP channels for calcium uptake, sodium-phosphate cotransporters etc.[2][4].

Other names
Mineral absorption pathwaysIntestinal mineral transport mechanismsMineral uptake in intestine
02

Biological functions

Nutrient absorptionElectrolyte homeostasisRegulation of mineral balance
03

Disease associations

Other (e.g., deficiencies or overloads of minerals such as iron, calcium, zinc)
04

Safety considerations

Malabsorption syndromes leading to deficiency statesToxicity from excessive absorption (e.g., hemochromatosis for iron)
05

Biomarkers

Serum levels of absorbed minerals (e.g., serum calcium, serum iron)Ferritin for iron statusParathyroid hormone for calcium regulation

Beyond the preview

Go deeper on Intestinal mineral absorption pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal mineral absorption pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call